Research & Development

gav成年网站不用播放器gav成网免费播放观看久久视频这里只精品99热南都电源老总醉驾 为何一个多月后披露?律师:未违规


  打開大門,秋風卷著黃葉涌進大門,長平沒有理會掛在衣裙上的黃葉,張開手,想要捉住一片黃葉,黃葉卻繞開了她探出去的手鑽進了房間終不可得,只好遺憾的嘆息道︰“原來已經到秋天了。”gav成年网站不用播放器   在這十一天中發生了很多事情。gav成网免费播放观看   因此,甦稚到了之後,將一干御醫當著皇帝的面罵的狗血淋頭,這些人只能低著頭不敢抬頭,更不敢多說一句話。   “我喜歡這個姿勢!”久久视频这里只精品99热   這一幕落在衛皇後眼中卻別有一份感慨。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo